CICigna Group
Hospital & Medical Service Plans
- Revenue
- $274.9B
- 11% YoY
- Operating margin
- 3.3%
- 12% YoY
- EBITDA
- $12.0B
- 1.8% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 1.9×
- $22.8B net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear161% of net incomeCash flow under 80% of net income
- Dilutive SBCClear0% of revenueOver 10% of revenue
- Payouts exceed cash flowClear54% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear29% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $174.1B | $180.5B | $195.3B | $247.1B | $274.9B | 11% |
| Operating income | $7.9B | $8.4B | $8.5B | $9.4B | $9.2B | 2.3% |
| Net income | — | — | $5.2B | $3.4B | $6.0B | 73% |
| Operating cash flow | $7.2B | $8.7B | $11.8B | $10.4B | $9.6B | 7.4% |
| Stock-based comp | $268M | $264M | $286M | $308M | $291M | 5.5% |
| Buybacks | $7.7B | $7.6B | $2.3B | $7.0B | $3.6B | 49% |
| Dividends | $1.3B | $1.4B | $1.4B | $1.6B | $1.6B | 2.8% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $175K · 1
- Net
- −$175K
Pay vs performance
No pay-versus-performance disclosure yet.